Navigation Links
Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
Date:1/16/2009

ROCHESTER, N.Y., Jan. 16 /PRNewswire/ -- Bausch & Lomb, the global eye health company, announced today that Peter Valenti, III, will join Bausch & Lomb as president, North America, Vision Care, effective later this month.

"Pete possesses deep leadership experience, as well as considerable eye health and general healthcare expertise," said Stuart Heap, corporate vice president and global president, Vision Care, Bausch & Lomb. "His appointment further strengthens our existing team, which is focused on delivering innovation in the contact lens, lens care and vision accessories segments of the industry."

Mr. Valenti was most recently vice president and general manager, Surgical Devices (U.S.), for Covidien, where he led sales and marketing strategy for its $1 billion product portfolio. Prior, he spent 12 years with Johnson & Johnson, serving in a variety of U.S. and international roles across consumer, pharmaceutical and device businesses. These included positions as vice president, Global Strategy, and vice president, U.S. Marketing, both in Vision Care. Before his career with Johnson & Johnson, he held several brand management roles with Procter & Gamble.

Mr. Valenti earned an MBA from the Johnson School of Management at Cornell University, and a Bachelor's degree from the University of Connecticut. He will be based in Rochester, N.Y.

About Bausch & Lomb

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for people around the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Bausch & Lomb is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO
2. SynCare Names Gloria Payne Vice President - Medical Management
3. HealthPlus Names Bruce Hill Interim President and CEO
4. Zimmer Holdings Names Betsy Bernard to Board of Directors
5. Bank of America Names Richard H. Vitale Leader of Not-for-Profit Healthcare and Institutions Practice
6. Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development
7. Shared Health(R) Names Adnane Khalil as Chief Information Officer
8. Davis Vision, Inc. Names Michael Ehrle Divisional Vice President of Sales
9. MDS Pharma Services Names Rudy Howard Chief Financial Officer
10. TransUnion Names New Vice President of Healthcare Information Solutions
11. Fast Radios Names Tekk X1000 Best New Two-Way Radio Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... the adoption of e-prescribing as measured in Part D Medicare data. The dataset, ... to pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") ...
(Date:4/26/2017)... ... 2017 , ... Infertility may be a result of an ... many women become pregnant upon treating their diagnosis. , To properly ... We can provide the necessary information to diagnose and treat your problem. ...
(Date:4/26/2017)... ... 26, 2017 , ... New SUPRO® XT55 Isolated Soy ... by helping beverage manufacturers more effectively manage protein costs. “Soy protein has always ... well as more stable pricing over time. Now it’s even more relevant as ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , ... . This new addition to the Mirroring360 product family combines device screen mirroring ... Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror app ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... , Tenn. and DALLAS , April ... EndoStim, Inc., announced that the first patients in ... the EndoStim device in the Lower Esophageal Sphincter Stimulation ... a minimally-invasive implantable device designed to provide long-term reflux ... neurostimulation. GERD affects nearly 65 million people ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: